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Reactive oxygen species play an important function in innate
immune cells
Reactive oxygen species (ROS) are key weapons against pathogenic bacteria and fungi in the
antimicrobial defense arsenal of host immunity. Innate immune cells, namely macrophages
and neutrophils, release ROS as cytotoxic effectors that can irreversibly oxidize and thus dam-
age cellular structures of the intruding pathogens. At the same time, ROS are important intra-
cellular mediators that drive the appropriate antimicrobial responses and tune the
inflammatory response. The best-recognized source of ROS in phagocytic cells is the NADPH
oxidase (NOX) complex [1]. However, mitochondria also contribute to the enhanced ROS
generation in these cells. This review focuses on the underappreciated but important roles of
mitochondrial ROS (mitoROS) in antimicrobial immune defenses.
Mitochondria are one of two main sources of ROS in innate
immune cells
ROS production in phagocytic cells is mainly mediated through the activity of the NOX com-
plex. Upon pathogen recognition and engulfment, the NOX complex is formed within the
phagosomal membranes, and it converts molecular oxygen into a highly reactive oxygen inter-
mediate—superoxide [2]. Subsequently, other reactive intermediates can arise from NOX-
derived superoxide depending on the pH levels, the presence of transitional metals, and other
enzyme activities in activated phagocytes [3].
The mitochondrion is another cellular source of ROS in infected immune cells that is often
overlooked. Interestingly, mitochondria produce low amounts of ROS even under normal, patho-
gen-free conditions. Superoxide can be generated at specific sites of the mitochondrial electron
transport chain (ETC), for instance, at complex I or complex III. This may occur because of the
escape of electrons from the electron carriers of the ETC to molecular oxygen [4–6].
Remarkably, the levels of mitoROS rise when phagocytes encounter microbes [7]. Studies
on murine macrophages point towards a specific mechanism responsible for the increased
mitoROS in infected cells. Upon macrophage activation, mitochondrial conditions favor
reverse electron transport in the ETC. The infection-associated increase in the activity of the
mitochondrial complex II likely leads to over-reduction of coenzyme Q, which is one of the
electron carriers in the ETC. Consequently, electrons from coenzyme Q travel to one of the
active sites of complex I, where, in turn, oxygen accepts electrons and forms superoxide [8,9].
Superoxide in mitochondria can be further converted into other ROS such as hydrogen perox-
ide (H2O2) in a reaction mediated by mitochondrial superoxide dismutase (Sod) [5]. Evidently
mitochondria contribute, along with NOX, to the increased production of ROS in immune
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cells during infection. Although mitochondrial generation of ROS in infected immune cells
has been well documented both in vitro and in vivo, the exact underlying mechanisms that
activate mitoROS production remain poorly defined.
Increased mitoROS production is induced specifically in infected
immune cells
Sensing pathogens through pattern recognition receptors can trigger enhanced mitoROS produc-
tion in immune cells. Once macrophages have recognized bacterial ligands via a subset of Toll-
like receptors (TLRs) such as TLR1, TLR2, and TLR4, mitochondria are then recruited to the pha-
gosomal membrane. The mammalian sterile 20-like kinases Mst1 and Mst2 are required for this
juxtaposition of mitochondria and phagosome [10]. Meanwhile, the binding of tumor necrosis
factor receptor-associated factor 6 (TRAF6) and a mitochondrial protein, evolutionarily conserved
signaling intermediate in Toll pathways (ECSIT), promotes the increase in mitoROS production
(Fig 1A) [11]. Interestingly, the TRAF6-ECSIT–dependent increase in mitoROS is required for
oxidative killing of internalized Salmonella typhimurium by macrophages [11]. TLRs also influ-
ence the accumulation of mitoROS inside the phagosome via induction of mitochondria-derived
vesicles. This happens when macrophages are challenged with Staphylococcus aureus [12]. In this
scenario, endoplasmic reticulum (ER) stress induces the generation of mitochondrial vesicles con-
taining Sod, which converts superoxide into H2O2 (Fig 1A) [12]. The functionality of TLR2/4/9 is
required for these vesicles to accumulate inside the pathogen-containing phagosome, and this
contributes to increased phagosomal concentrations of antibacterial H2O2.
TLR4 signaling is also linked to enhanced mitoROS generation, which in turn affects
inflammation. This is observed in macrophages infected with Escherichia coli. Here, the
increase in mitoROS is mediated by crosstalk between activated NOX and mitochondria (Fig
1B) [8]. Upon infection with live E. coli, NOX-derived ROS in macrophages react with the
redox-sensitive Src-type tyrosine kinase, Fgr, which is activated in response to ROS exposure
[8,13]. Fgr then increases the enzymatic activity of mitochondrial complex II, creating condi-
tions for mitoROS production through reverse electron transport. The elevation of complex II
activity, and thus the increase in mitoROS production, enhances accumulation of proinflam-
matory cytokine interleukin (IL)-1β, which in turn leads to the activation of the inflammatory
program promoting bacterial killing [8]. This correlates well with the established notion that
mitoROS positively regulate inflammasome formation and thus activate IL-1β [14].
Proinflammatory cytokines also increase mitoROS formation in infected immune cells.
Cytokines such as interferon γ (IFNγ) and tumor necrosis factor (TNF) induce mitoROS pro-
duction, which is essential for the elimination of Listeria monocytogenes and Mycobacteria
tuberculosis [15–17]. However, the generation of mitoROS has to occur in a controlled manner
to avoid host cell damage. Indeed, excessive TNF elevates levels of mitoROS and causes an
overload of mitochondrial calcium in macrophages infected with M. tuberculosis. This ulti-
mately results in the necrosis of macrophages and a release of bacteria to the extracellular envi-
ronment, thereby exacerbating the infection [17].
Taken together, these findings show that mitoROS production can be induced specifically
in infected immune cells. Triggering this system leads to the direct growth inhibition of the
pathogen and the induction of inflammatory programs.
Infection-associated redox reactions enable regulatory properties
of ROS
The direct antimicrobial function of ROS in immune cells is mainly accomplished by creating
oxidative stress and damaging cellular components of invading pathogens. As described
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above, signaling via mitoROS also contributes to antimicrobial immunity. However, little is
known about the mechanisms behind the signaling properties of ROS, especially mitoROS, in
infected immune cells. One possible mechanism is through the induction of oxidative modifi-
cations in regulatory proteins, which directly or indirectly mediate the synthesis of cytokines.
For instance, in L. monocytogenes-infected macrophages, mitoROS are responsible for the for-
mation of disulfide bridges in the NF-κB essential modulator (NEMO), which are required for
dimerization of this protein (Fig 1B) [18]. Accordingly, the mitoROS-regulated formation of
NEMO dimers induces a cascade of signaling reactions that subsequently leads to the secretion
of proinflammatory cytokines, including IL-1β, TNFα, and IL-6 [18]. Therefore, mitoROS-
mediated modifications of cellular regulators are involved in transforming macrophages into a
proinflammatory state required to combat pathogens.
Fig 1. ROS contribute to the direct killing of microbes and regulate the production of proinflammatory cytokines. (A) TLR signaling increases the production of
antibacterial mitoROS. MitoROS can reach the pathogen-containing phagosome because of the close proximity of mitochondria and phagosome. Juxtaposition of
mitochondria and phagosome is regulated by the kinases Mst1 and Mst2, which act by activating small GTPase Rac. The activated Rac is required for translocation of
the TLR signaling component TRAF6 to mitochondria [10]. Here, TRAF6 reacts with mitochondrial ECSIT, which is responsible for an assembly of the ETC complex
I. The engagement of TRAF6 with mitochondrial ECSIT promotes the ubiquitination of the latter, which consequently augments mitoROS formation through
disassembly of complex I of the ETC [11]. MitoROS can also reach phagosome through mitochondria-derived vesicles containing Sod [12]. TLRs activate ERE1α in the
ER of infected phagocytes. Activated ERE1α promotes the formation of mitochondrial vesicles, which become accumulated inside the phagosome. These vesicles
contain superoxide dismutase and thus contribute to mitoROS accumulation in the pathogen-containing phagosome [12]. (B) TLR signaling promotes inflammation
through mitoROS. TLR signaling elevates generation of cytosolic ROS through the activity of NOX. Cytosolic ROS cause oxidation and a subsequent activation of
redox-sensitive Src-type tyrosine kinase Fgr [13]. The activated Fgr increases the activity of mitochondrial complex II, which is required for the increase in mitoROS
production via reverse electron transport in the ETC. MitoROS, in turn, may increase levels of proinflammatory cytokine IL1β, probably via inflammasome activation
[8]. Independently of the activities of NOX, mitoROS can induce inflammation in response to invading pathogens. TLR signaling through TRAF6 can induce mitoROS
generation in response to infection. Increased mitoROS levels induce oxidative modifications, in particular, intramolecular disulfide bonds, in NEMO. This redox
modification of NEMO is required for binding and activating the IKK complex and leads to the activation of ERK1 and ERK2 and NF-κB pathways to increase the
synthesis of proinflammatory cytokines IL1β, TNFα, and IL6 [18]. ECSIT, evolutionarily conserved signaling intermediate in Toll pathways; ERE1α, inositol-requiring
enzyme 1α; ERK1/2, extracellular signal-regulated protein kinase 1/2; ETC, electron transport chain; Fgr, Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene
homolog; IKK, inhibitor of nuclear factor-κB (IκB) kinase; IL, interleukin; mitoROS, mitochondrial ROS; MST1/2, mammalian sterile 20-like kinases; NEMO, NF-κB
essential modulator; NOX, NADPH oxidase; Rac, small guanosine triphosphate-binding protein; ROS, reactive oxygen species; Sod, superoxide dismutase; Src, proto-
oncogene tyrosine-protein kinase; TLR, Toll-like receptor; TNFα, tumor necrosis factor α; TRAF6, tumor necrosis factor receptor-associated factor 6.
https://doi.org/10.1371/journal.ppat.1008470.g001
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Induction of mitoROS in immune cells is required to resist infection
ROS modulate the antimicrobial functions of innate immune cells by inhibiting the growth of
invading pathogens as well as regulating inflammatory responses. Disruption of ROS-medi-
ated processes leads to the inability of the host to clear the pathogens. A pathology such as
chronic granulomatous disease, which is associated with the reduced production of ROS
through NOX, is characterized by increased susceptibility to bacterial and fungal infections
[19,20]. Another human immunodeficiency syndrome, which occurs because of a mutation in
the gene encoding Rac2, is characterized by impaired NOX-derived and mitoROS production
by phagocytic cells and associated with severe bacterial infections [10,21]. The importance of
mitoROS for the host to clear microbes has been also proven in mouse models of infection.
Mice that are deficient in proteins responsible for the induction of mitoROS are highly suscep-
tible to infections caused by S. typhimurium and L. monocytogenes [11,16]. Similar to NOX-
derived ROS [22], mitoROS also impact the rate of cytokine production during infection and
thus play an essential role in regulating inflammation in vivo [8,9].
Elevated levels of mitoROS may exhibit detrimental properties
Despite an essential role of mitoROS in antimicrobial responses of immune cells, mitoROS
may also be responsible for damage of the host during infection. In particular, mitoROS may
cause organ failure in several models of sepsis [23,24]. In corroboration, administration of spe-
cific inhibitors of mitoROS protect animals against organ damage in the lipopolysaccharide–
peptidoglycan model of sepsis and lipopolysaccharide-induced endotoxemia [23,24] but do
not exhibit a long-term beneficial effect in polymicrobial sepsis [25]. Moreover, mitoROS may
contribute to exaggerated immune responses during viral infections such as infection with
influenza A virus [26]. Accordingly, a pharmacological inhibitor of mitoROS, MitoTempo,
can prevent lung inflammation and thus reduce mortality of mice infected with influenza A
virus [26]. The harmful effects of mitoROS in these models might be associated with mito-
chondrial dysfunction, as well as impaired redox homeostasis. This possible correlation awaits
further investigation.
Future perspective
Multiple studies have proven the important role of mitoROS for antimicrobial immunity. To
translate this knowledge into therapeutic opportunities, further mechanistic insights into the
mode of action of mitoROS are needed. ROS act by reacting with various molecules such as
DNA, proteins, or lipids. Functions or localization of these redox-sensitive molecules might be
altered because of exposure to ROS. For instance, oxidative protein modifications may activate
or inhibit protein functions. Thus, to fully understand the impact of the increased mitoROS
levels in infected immune cells, cellular targets of mitoROS such as redox-sensitive proteins
need to be defined. Also, mitoROS may alter permeability of mitochondrial membranes and
thus act through releasing mitochondrial components into other cellular compartments.
Indeed, in activated immune cells, mitoROS production leads to membrane permeability tran-
sition (MPT) and a subsequent release of mitochondrial DNA into the cytosol, where it
increases concentrations of IL-1β [27]. The mechanisms behind the activation of MPT by
mitoROS in the context of infection require further investigation.
As discussed here, mitoROS are important against pathogenic bacteria, but their function
against pathogenic fungi is unknown. Thus, more studies are required to explore whether
mitoROS also play an important role in antifungal immunity. Finally, besides being major
effectors of the innate immunity, mitoROS also contribute to the induction and regulation of
adaptive immune responses. For example, mitoROS play an essential role in the processes of
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antigen presentation by plasmacytoid dendritic cells [28]. Moreover, it is established that
mitoROS levels affect T cell formation [29]. Currently, the exact molecular mechanisms by
which mitoROS orchestrate adaptive immunity against pathogens remain largely unexplored.
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